Thu. 25 Apr 2024, 4:06pm ET
Benzinga
Earnings, Earnings Beats, News
ResMed (NYSE:RMD) reported quarterly earnings of $2.13 per share which beat the analyst consensus estimate of $1.91 by 11.52 percent. The company reported quarterly sales of $1.200 billion which beat the analyst consensus estimate of $1.167 billion by 2.82 percent. This is a 7.44 percent increase over sales of $1.117 billion the same period last year.